A practical framework for policymakers, elected representatives and civil-society advocates. This brief makes the case for closing the structural gap in menopause policy, shows how governments and advocates are turning recognition into action, and offers a framework to act on.
Menopause is a near-universal life transition, yet it has been barely discussed in doctors' offices, workplaces and homes, almost never reaching research, training or policy. That silence is breaking. Lived-experience advocacy, journalism, social media, parliamentary attention and civil-society organising have moved menopause from a private matter onto public record and into political debate.
Menopause affects half the world's population, typically between the ages of 45 and 55. Symptoms can last seven years or longer, and menopause carries long-term risks to cardiovascular, bone, brain and metabolic health that extend well beyond the years of visible symptoms. For women with significant symptoms or limited access to care, the consequences extend beyond health into work, family life and financial security.
Reproductive-health policy and clinical training typically end in a woman's 40s. What follows, general ageing and chronic-disease policy, was never built with women specifically in mind. Menopause falls into the institutional void between the two. No country can claim to deliver Universal Health Coverage across the life course while an entire stage of women's health goes largely unserved.
Menopause is also rarely captured in national health data. Major global survey platforms have traditionally focused on women aged 15–49, leaving menopause poorly represented in the evidence used for national planning. The result is a consistent pattern: limited provider training, uneven services, and care that depends on geography, income and a woman's ability to navigate the system.
Effective menopause policy cannot rest on a single law, clinical guideline or workplace initiative. The framework below is both a roadmap for action and a diagnostic tool for assessing whether recognition is translating into equitable delivery.
Women can obtain timely, affordable, evidence-based assessment, treatment, referral and follow-up through primary, community or specialist care.
Policy test: Can women access affordable, evidence-based care locally, whatever their income or geography? Who is excluded?
Integrate menopause into primary care, women's health, NCD or healthy-ageing services; address timely access, treatment and medicine availability, insurance coverage, continuity and cost.
Providers are trained and supported to recognise, manage and refer menopause-related concerns.
Policy test: Are clinicians and frontline health workers trained to assess, treat and refer, and supported to keep their knowledge current as guidance evolves?
Issue or update national evidence-based clinical guidance; integrate menopause into pre-service and continuing education for medical, nursing, pharmacy and community health workers; establish clear care and referral pathways.
Women are supported to remain healthy and engaged in work.
Policy test: Do labour and social-protection policies extend beyond formal employment to reach informal, temporary and precarious work, and are they enforceable?
Lead through public-sector guidance; support employer policies, HR, manager and occupational-health training, flexible work and reasonable adjustments; extend social-protection coverage to informal, temporary and precarious workers.
Menopause is recognised in relevant policy, legal or institutional frameworks, with responsibility, financing and coordination assigned.
Policy test: Are responsibilities, financing and legal protections in place? Is there stakeholder participation and open monitoring of implementation and equity?
Use strategies, legislation, regulation, budget processes, parliamentary inquiry, formal policy commitments or legal protections to create implementation and reporting accountability.
Women, families, employers and providers have trusted, accessible information.
Policy test: Do women and their communities recognise symptoms, feel comfortable discussing them, and know where to find trusted care?
Fund public information, health literacy, community engagement, community-health-worker outreach and civil-society partnerships to reduce stigma, counter misinformation and support care-seeking.
Population need, service availability, service use, treatment, access, outcomes and inequalities are measured.
Policy test: Is menopause in research agendas and national health tracking, with data disaggregated to show who is left behind?
Include menopause in surveys, routine data collection and research agendas; establish periodic policy review; disaggregate by geography, income, education, health literacy, employment status and disability.
Progress is rarely simultaneous across all six components. Six countries illustrate different entry points: a clinical standard, a workplace policy, a parliamentary inquiry, each shaped by their institutions, advocates and health systems.
Brazil's response is being built through a legislative pathway within its Unified Health System (SUS). A notable rise in federal and state menopause bills has been accompanied by clinical leadership on guidelines, a 2026 menopause care manual and national training for primary healthcare professionals.
In 2023 the government introduced a Menopause in the Workplace Policy Framework for Civil Service organisations, while successive Women's Health Action Plans supported specialist menopause clinics and guidance for general practice. Since June 2025, eligible women can obtain prescribed HRT free through participating pharmacies.
Kenya's National Reproductive Health Policy 2022–2032 identifies menopause among reproductive-health needs. A 2025 conference led by ICRW Africa and the Reproductive Health Network Kenya secured Ministry of Health recognition of menopause as a neglected public-health issue and a commitment to develop national guidelines.
Mexico was early to set a mandatory clinical standard for menopause care in 2012, though it ceased to be in force in 2023. Political momentum has since grown through parliamentary forums and legislative proposals, national training of roughly 4,700 physicians, and a life-course women's-health protocol (PRONAM) expected in late 2026.
The 2023 reform of Spain's sexual and reproductive health law incorporated the climacteric and menopause into healthcare, education, awareness and research policy. A 2025 cross-party parliamentary resolution, a national awareness campaign and a 2026 commitment to triple women's-health research funding have followed, with Catalonia moving faster at regional level.
A Private Member's Bill, an All-Party Parliamentary Group and a Committee inquiry built into the Women's Health Strategy for England, a UK Menopause Taskforce and new employer duties under the Employment Rights Act 2025. Scotland has gone furthest in organising health-service delivery.
"The UK shows what becomes possible when women speak openly and parliamentarians listen. Now we must take that momentum into a truly global movement."— Carolyn Harris MP
Governments do not need to wait for a perfect national strategy. There is no wrong first step. What determines success is whether initial recognition translates into funded implementation, clear institutional responsibility and measurable accountability.
Build and sustain political momentum. Legislative groups, caucuses, inquiries and hearings can keep menopause visible, bring evidence and lived experience into public decision-making, and test whether government commitments are funded and reaching all women.
Turn recognition into systems change. Integrate menopause into existing health, labour, gender-equality, social-protection and ageing systems, assign clear responsibility, secure financing, set delivery standards and measure outcomes. Lead by example as employers.
Connect policy to lived experience and keep pressure on implementation and equity. Build coalitions across sectors, bring diverse women's experiences into decision-making, and monitor delivery so that policies reach women beyond the most visible or advantaged groups.
The complete brief includes the full country case studies, the six-component framework with policy levers and tests, and the evidence base behind the economic case.
Download at the top of this post